Continued progress against cancer will require collaboration among all key stakeholders. To this end, more stable and sustained federal investment is essential.
Founder Elina Onitskansky’s Ilant Health has raised over $22 million to pair weight loss drugs with dietitians, behavioral health and peer support.
Decisions by health insurers to trim the size of their geographic footprints is a way to boost bottom lines as reimbursement flattens and cost of care increases.
Restaurant chains are shrinking portions and loading up on protein for diners on GLP-1 weight-loss drugs. A doctor analyzes how the changes may affect GLP-1 users.
Maria Shriver, founder of the Women’s Alzheimer’s Movement, talked about how less than 20 percent of women realized that women are at higher risk for Alzheimer’s Disease.
Americans pay 3x higher than other countries for prescription drugs? A doctor breaks down 8 ways the Trump administration aims to lower prices, and which might work.
A doctor breaks down what women need to know about breast cancer awareness month.
Given what some experts and clinicians cite as a lack of clear evidentiary benefit, FDA approval doesn’t guarantee reimbursement of multi-cancer early detection tests.
A rare inherited EGFR mutation raises lung cancer odds 25-fold overall and more than 60-fold in never-smokers, revealing why some nonsmokers develop lung cancer.
With Medicare Advantage premiums to drop by 16% in 2027, this could further boost the percentage of seniors and disabled folks who choose the privately run alternative.